Pharmaceuticals Packaging Market Research Report 2033

Report Description

Pharmaceuticals Packaging Market Outlook

According to our latest research, the global pharmaceuticals packaging market size reached USD 138.5 billion in 2024, reflecting the sectorÂ’s robust expansion driven by evolving healthcare demands and stringent regulatory requirements. The market is expected to maintain a strong growth trajectory with a CAGR of 6.7% from 2025 to 2033, reaching a forecasted value of USD 250.5 billion by 2033. This steady growth is primarily attributed to the increasing prevalence of chronic diseases, advancements in drug formulations, and the surge in demand for safe, secure, and convenient packaging solutions across the pharmaceutical industry.

The growth of the pharmaceuticals packaging market is propelled by several key factors. One of the most prominent is the rising global demand for pharmaceuticals, spurred by aging populations, higher incidences of chronic illnesses, and the expansion of healthcare infrastructure in emerging economies. As pharmaceutical products become more sophisticated, there is a growing need for packaging that ensures product integrity, extends shelf life, and complies with rigorous regulatory standards. Furthermore, the industry’s focus on patient-centric packaging — including features like child-resistant closures, dose accuracy, and easy-to-open formats — has driven innovation in packaging design and materials. The adoption of smart packaging technologies, such as RFID tags and tamper-evident seals, is also enhancing supply chain security and traceability, further fueling market growth.

Another crucial growth driver is the increasing emphasis on sustainability and environmental responsibility within the pharmaceuticals packaging sector. Regulatory authorities and consumers alike are demanding eco-friendly packaging solutions that minimize the use of plastics, promote recyclability, and reduce carbon footprints. This has led to the development and commercialization of biodegradable materials, recyclable plastics, and paper-based alternatives. Pharmaceutical companies are responding by integrating sustainable practices into their packaging operations, seeking to balance product safety with environmental stewardship. The trend towards green packaging is expected to intensify over the forecast period, supported by government initiatives and corporate sustainability goals.

Technological advancements in packaging machinery and automation are also playing a pivotal role in the expansion of the pharmaceuticals packaging market. The implementation of advanced filling, sealing, and labeling systems has significantly improved packaging efficiency, accuracy, and scalability. Automation not only reduces labor costs and human error but also enhances compliance with Good Manufacturing Practices (GMP) and regulatory standards. Additionally, the integration of digital technologies, such as serialization and track-and-trace solutions, is helping combat counterfeiting and ensuring the authenticity of pharmaceutical products throughout the supply chain. These innovations are expected to drive further growth and competitiveness in the market.

Ampoules packaging plays a crucial role in the pharmaceuticals industry, particularly for injectable drugs and vaccines. These small, sealed vials are designed to maintain the sterility and integrity of their contents, ensuring that medications remain effective and safe for patient use. The demand for ampoules packaging is increasing as the industry shifts towards more biologics and biosimilars, which often require precise and secure packaging solutions. The COVID-19 pandemic further highlighted the importance of reliable ampoules packaging, as it was essential for the distribution of vaccines worldwide. Innovations in ampoules design, such as the use of break-resistant materials and improved sealing techniques, are enhancing their functionality and safety.

From a regional perspective, North America continues to dominate the pharmaceuticals packaging market, accounting for a substantial share due to its advanced healthcare infrastructure, high pharmaceutical consumption, and stringent regulatory landscape. Europe follows closely, benefiting from strong R&D investments and a mature pharmaceutical industry. However, the Asia Pacific region is emerging as the fastest-growing market, driven by rapid urbanization, increasing healthcare expenditures, and the expansion of pharmaceutical manufacturing hubs in countries like China and India. Latin America and the Middle East & Africa are also witnessing steady growth, supported by improving access to healthcare and the expansion of local pharmaceutical industries. The global pharmaceuticals packaging market is thus characterized by dynamic regional trends, with each region presenting unique opportunities and challenges for market participants.

Get Free Sample Report

Packaging Type Analysis

The pharmaceuticals packaging market is segmented by packaging type, which includes blister packs, bottles, ampoules, vials, sachets, tubes, and others. Blister packs remain one of the most widely used packaging formats, especially for solid oral dosage forms such as tablets and capsules. The popularity of blister packs is attributed to their ability to offer excellent protection against moisture, light, and contamination, thereby preserving the efficacy and shelf life of pharmaceuticals. Additionally, blister packaging supports patient compliance by enabling unit-dose dispensing and clear product identification. Innovations in blister pack materials and designs, such as push-through and peelable foils, are further enhancing their usability and appeal in the market.

Bottles, both plastic and glass, are another significant segment within pharmaceuticals packaging. They are primarily used for liquid formulations, syrups, and bulk oral medications. Plastic bottles are favored for their lightweight nature, durability, and cost-effectiveness, while glass bottles are preferred for their chemical inertness and superior barrier properties. The demand for bottles is particularly high in pediatric and geriatric medicine, where dosing flexibility and ease of administration are critical. Recent advancements in bottle design, including tamper-evident closures and child-resistant caps, are addressing safety concerns and regulatory requirements, contributing to the sustained growth of this segment.

Ampoules and vials are essential packaging types for injectable pharmaceuticals, biologics, and vaccines. Ampoules, typically made of glass, provide a hermetically sealed environment that ensures sterility and prevents contamination. Vials, available in both glass and plastic variants, offer versatility for single-dose and multi-dose applications. The rising demand for injectable drugs, fueled by the growth of biologics and biosimilars, is driving the adoption of ampoules and vials. Moreover, the COVID-19 pandemic underscored the importance of reliable packaging for vaccines and injectables, leading to increased investments in high-quality vial and ampoule production.

The significance of ampoules packaging extends beyond just maintaining sterility; it also addresses the growing need for sustainable packaging solutions. As regulatory bodies and consumers push for environmentally friendly practices, the development of recyclable and biodegradable ampoules is gaining traction. Pharmaceutical companies are investing in research to create ampoules that not only protect their contents but also minimize environmental impact. This shift towards sustainable ampoules packaging is expected to align with broader industry trends, supporting corporate sustainability goals while ensuring compliance with emerging regulations. The integration of eco-friendly materials in ampoules packaging is a promising step towards a more sustainable future in pharmaceuticals.

Sachets and tubes are gaining traction as convenient packaging solutions for topical, oral, and reconstitutable medications. Sachets are particularly popular for single-dose powders, granules, and liquids, offering portability and ease of use. Tubes, often used for creams, gels, and ointments, provide excellent protection against external contaminants and enable precise dispensing. The growing demand for over-the-counter (OTC) pharmaceuticals and personal care products is boosting the use of sachets and tubes. Manufacturers are focusing on improving barrier properties, user-friendliness, and sustainability in these packaging types to meet evolving consumer and regulatory expectations.

Other packaging types, such as pouches, cartridges, and pre-filled syringes, are also gaining prominence in the pharmaceuticals packaging market. Pre-filled syringes, in particular, are witnessing rapid adoption due to their convenience, safety, and ability to minimize dosing errors. These specialized packaging formats are increasingly used for biologics, vaccines, and high-value drugs. As the pharmaceutical industry continues to innovate in drug delivery and formulation, the demand for diverse and advanced packaging types is expected to rise, offering new growth opportunities for market players.

Report Scope

Material Analysis

The choice of material is a critical consideration in pharmaceuticals packaging, with plastic, glass, paper & paperboard, aluminum foil, and other materials dominating the market. Plastic is the most widely used material, favored for its versatility, lightweight, and cost-effectiveness. Plastics such as polyethylene (PE), polypropylene (PP), and polyethylene terephthalate (PET) are commonly employed in bottles, blister packs, and flexible packaging. The ability to mold plastics into various shapes and sizes, coupled with advancements in barrier properties and recyclability, has solidified their position as the material of choice for many pharmaceutical applications. However, environmental concerns and regulatory pressures are prompting manufacturers to explore biodegradable and recyclable plastic alternatives.

Glass remains the preferred material for packaging injectable pharmaceuticals, biologics, and sensitive formulations, owing to its exceptional chemical inertness, impermeability, and transparency. Glass ampoules and vials ensure product stability and sterility, making them indispensable for high-value and temperature-sensitive drugs. Despite its advantages, glass is susceptible to breakage and higher transportation costs, leading to increased interest in lightweight and shatter-resistant alternatives. Innovations in glass manufacturing, such as borosilicate and aluminosilicate compositions, are enhancing the durability and safety of glass packaging, ensuring its continued relevance in the market.

Ampoules packaging is also evolving with the advent of smart packaging technologies. The incorporation of features like RFID tags and QR codes in ampoules allows for enhanced traceability and authentication, which is crucial in combating counterfeit drugs. These technologies enable real-time tracking of ampoules throughout the supply chain, ensuring that they reach their intended destinations without tampering. This not only enhances patient safety but also provides valuable data for pharmaceutical companies to optimize their logistics and inventory management. As the industry continues to embrace digitalization, ampoules packaging is set to become an integral part of the smart packaging revolution, offering new opportunities for innovation and efficiency.

Paper & paperboard are gaining popularity as sustainable packaging materials for secondary and tertiary packaging applications. They are widely used for cartons, labels, inserts, and outer packaging, offering excellent printability and branding opportunities. The shift towards eco-friendly packaging solutions is driving the adoption of paper-based materials, supported by advancements in coating technologies that improve moisture resistance and durability. Pharmaceutical companies are increasingly incorporating recycled and certified paper products into their packaging portfolios to meet sustainability targets and regulatory requirements.

Aluminum foil is a critical material in pharmaceuticals packaging, particularly for blister packs, sachets, and strip packs. Its superior barrier properties against moisture, oxygen, and light make it ideal for protecting sensitive drugs and extending shelf life. Aluminum foil is also used in combination with other materials to create multi-layer laminates that enhance packaging performance. The recyclability of aluminum further supports its use in sustainable packaging initiatives. However, fluctuations in raw material prices and the energy-intensive nature of aluminum production present challenges for manufacturers.

Other materials, such as laminates, elastomers, and specialty polymers, are used for specific pharmaceutical packaging applications requiring unique performance attributes. For example, elastomeric closures are essential for sealing injectable vials and ensuring sterility. Laminates combining multiple materials offer tailored barrier properties and mechanical strength. As the pharmaceutical industry continues to innovate in drug formulation and delivery, the demand for advanced and customized packaging materials is expected to grow, driving further research and development in this segment.

Product Analysis

The pharmaceuticals packaging market is categorized by product into primary, secondary, and tertiary packaging. Primary packaging refers to the immediate container that comes into direct contact with the drug, such as blister packs, bottles, vials, and ampoules. The primary packaging segment holds the largest market share, driven by the need to ensure drug safety, efficacy, and compliance with regulatory standards. Innovations in primary packaging focus on enhancing barrier properties, patient convenience, and tamper resistance. The rise of biologics, personalized medicine, and self-administration devices is further boosting demand for advanced primary packaging solutions that support drug stability and accurate dosing.

Secondary packaging encompasses the outer packaging that groups primary packages together, such as cartons, boxes, and labels. Secondary packaging plays a crucial role in branding, product information, and logistics. It also provides an additional layer of protection against physical damage and environmental factors during transportation and storage. The growing emphasis on product differentiation and regulatory compliance is driving investments in high-quality secondary packaging with features like anti-counterfeiting elements, serialization, and user-friendly designs. The trend towards sustainable and recyclable secondary packaging materials is also gaining momentum, reflecting broader industry efforts to reduce environmental impact.

Tertiary packaging involves bulk packaging used for the transportation and distribution of pharmaceutical products. This includes pallets, crates, and large shipping containers designed to protect multiple secondary packages during long-distance transit. Tertiary packaging is essential for maintaining product integrity throughout the supply chain, especially in international trade and large-scale distribution networks. The increasing globalization of pharmaceutical manufacturing and distribution is driving demand for robust and cost-effective tertiary packaging solutions. Innovations in this segment focus on improving traceability, automation, and sustainability, such as the use of reusable pallets and eco-friendly materials.

The interplay between primary, secondary, and tertiary packaging is becoming increasingly important as pharmaceutical companies seek to optimize their packaging strategies for efficiency, safety, and sustainability. Integrated packaging solutions that streamline the packaging process, reduce waste, and enhance supply chain visibility are gaining traction in the industry. Regulatory requirements for serialization and track-and-trace capabilities are also influencing product design across all packaging levels. As the pharmaceuticals packaging market evolves, the demand for holistic and innovative packaging solutions that address the unique needs of each product category is expected to rise.

Furthermore, the growing adoption of automation and digital technologies in packaging operations is transforming the product landscape. Automated packaging lines, smart labeling systems, and real-time monitoring tools are enhancing the quality, consistency, and scalability of pharmaceutical packaging. These advancements are enabling manufacturers to meet the increasing demand for high-volume, high-quality packaging while maintaining compliance with stringent industry standards. The integration of digital technologies across primary, secondary, and tertiary packaging is expected to drive further innovation and competitiveness in the market.

Drug Delivery Mode Analysis

The pharmaceuticals packaging market is further segmented by drug delivery mode, including oral, injectable, topical, inhalable, and others. Oral drug delivery remains the most prevalent mode, accounting for a significant share of the market. Packaging solutions for oral drugs, such as tablets, capsules, and liquids, focus on ensuring dose accuracy, protecting against moisture and contamination, and enhancing patient compliance. Blister packs, bottles, and sachets are commonly used for oral medications, with innovations targeting child-resistant features, easy-open designs, and unit-dose dispensing. The rising demand for over-the-counter (OTC) medications and self-administered therapies is driving growth in this segment.

Injectable drug delivery is a rapidly growing segment, fueled by the increasing use of biologics, vaccines, and specialty drugs that require parenteral administration. Packaging solutions for injectables, including vials, ampoules, pre-filled syringes, and cartridges, must meet stringent requirements for sterility, barrier protection, and compatibility with sensitive formulations. The COVID-19 pandemic highlighted the critical importance of reliable packaging for vaccines and injectables, leading to significant investments in this area. Innovations such as dual-chamber syringes, auto-injectors, and tamper-evident closures are enhancing the safety, convenience, and usability of injectable packaging.

Topical drug delivery, which includes creams, ointments, gels, and transdermal patches, requires packaging that protects against contamination, ensures product stability, and facilitates precise application. Tubes, jars, and airless pumps are commonly used for topical formulations. The increasing prevalence of dermatological conditions and the growing popularity of cosmeceuticals are driving demand for advanced topical packaging solutions. Manufacturers are focusing on improving barrier properties, user-friendliness, and sustainability in this segment to meet evolving consumer and regulatory expectations.

Inhalable drug delivery is a specialized segment that includes packaging for metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizer solutions. These packaging formats must ensure dose accuracy, product stability, and ease of use for patients with respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The growing incidence of respiratory diseases and the development of novel inhalable therapies are driving innovation in inhalable packaging. Features such as dose counters, child-resistant mechanisms, and recyclable materials are gaining importance in this segment.

Other drug delivery modes, such as buccal, nasal, and rectal, require specialized packaging solutions tailored to the unique requirements of each route of administration. As pharmaceutical companies continue to explore new drug delivery technologies and formulations, the demand for customized and high-performance packaging solutions is expected to grow. The integration of smart packaging features, such as electronic dose monitoring and patient engagement tools, is also emerging as a key trend across all drug delivery modes, enhancing patient adherence and outcomes.

End-User Analysis

The pharmaceuticals packaging market serves a diverse range of end-users, including pharmaceutical companies, contract packaging organizations (CPOs), retail pharmacies, and others. Pharmaceutical companies are the primary end-users, accounting for the largest share of the market. These companies require high-quality, compliant, and innovative packaging solutions to protect their products, ensure regulatory compliance, and differentiate their brands. The increasing complexity of drug formulations and delivery systems is driving demand for customized packaging solutions that address specific product requirements. Pharmaceutical companies are also investing in sustainable packaging initiatives to align with corporate social responsibility goals and meet consumer expectations.

Contract packaging organizations (CPOs) play a vital role in the pharmaceuticals packaging market by providing specialized packaging services to pharmaceutical manufacturers. The outsourcing of packaging operations to CPOs is gaining traction as companies seek to reduce costs, enhance flexibility, and focus on core competencies. CPOs offer expertise in packaging design, material selection, regulatory compliance, and supply chain management, enabling pharmaceutical companies to accelerate product launches and respond to market dynamics. The growing trend towards contract manufacturing and packaging is expected to drive significant growth in this segment.

Retail pharmacies are important end-users of pharmaceuticals packaging, particularly for over-the-counter (OTC) medications, unit-dose packaging, and patient-specific dispensing. Packaging solutions for retail pharmacies focus on convenience, safety, and regulatory compliance. The increasing demand for personalized medicine and customized packaging formats is driving innovation in this segment. Retail pharmacies are also adopting smart packaging technologies, such as RFID tags and tamper-evident seals, to enhance product security and traceability.

Other end-users, such as hospitals, clinics, and healthcare institutions, require specialized packaging solutions for bulk medications, parenteral drugs, and unit-dose dispensing. These end-users prioritize packaging that ensures product integrity, facilitates efficient medication management, and supports infection control protocols. The expansion of healthcare infrastructure and the increasing adoption of automation in hospital pharmacies are driving demand for advanced packaging solutions in this segment.

The evolving needs of end-users are shaping the future of the pharmaceuticals packaging market. Manufacturers are increasingly focusing on developing tailored packaging solutions that address the specific requirements of each end-user segment. Collaboration between pharmaceutical companies, CPOs, and packaging suppliers is becoming more prevalent, enabling the development of innovative, efficient, and sustainable packaging solutions that enhance patient safety and outcomes.

Opportunities & Threats

The pharmaceuticals packaging market is poised for significant opportunities driven by technological advancements and the growing emphasis on patient-centric solutions. The integration of smart packaging technologies, such as RFID, QR codes, and electronic dose monitoring, presents a transformative opportunity for the industry. These innovations enhance supply chain transparency, combat counterfeiting, and improve patient adherence by providing real-time information and reminders. Additionally, the shift towards personalized medicine and targeted therapies is creating demand for customized packaging solutions that support individualized dosing and administration. Companies that invest in digitalization and smart packaging are well-positioned to capitalize on these emerging trends and gain a competitive edge in the market.

Sustainability is another major opportunity area for the pharmaceuticals packaging market. Increasing regulatory scrutiny and consumer awareness are driving the adoption of eco-friendly packaging materials and processes. The development of biodegradable plastics, recyclable materials, and paper-based packaging solutions is gaining momentum, supported by advancements in material science and manufacturing technologies. Pharmaceutical companies that prioritize sustainability in their packaging operations can enhance brand reputation, meet regulatory requirements, and attract environmentally conscious consumers. Collaboration across the value chain, from material suppliers to end-users, is essential to drive the adoption of sustainable packaging solutions and achieve long-term industry goals.

Despite the positive outlook, the pharmaceuticals packaging market faces several restraining factors. One of the primary challenges is the stringent and evolving regulatory landscape governing pharmaceutical packaging. Compliance with global and regional regulations, such as the U.S. FDA, EMA, and WHO guidelines, requires significant investments in quality assurance, documentation, and testing. The complexity of regulatory requirements, coupled with the need for continuous updates and audits, can increase operational costs and delay product launches. Additionally, fluctuations in raw material prices, supply chain disruptions, and the risk of counterfeiting pose ongoing threats to market stability. Companies must remain agile and proactive in addressing these challenges to sustain growth and competitiveness in the pharmaceuticals packaging market.

Regional Outlook

North America dominates the pharmaceuticals packaging market, accounting for approximately 34% of the global market share in 2024, equivalent to USD 47.1 billion. The regionÂ’s leadership is driven by advanced healthcare infrastructure, high pharmaceutical consumption, and a strong focus on regulatory compliance. The presence of leading pharmaceutical companies, robust R&D investments, and a well-established packaging industry further contribute to North AmericaÂ’s market dominance. The United States, in particular, is a major contributor, with ongoing investments in biologics, specialty drugs, and smart packaging technologies. The region is expected to maintain steady growth over the forecast period, supported by ongoing innovation and regulatory advancements.

Europe follows closely, holding a market share of around 28%, or USD 38.8 billion, in 2024. The European pharmaceuticals packaging market benefits from a mature pharmaceutical industry, strong regulatory frameworks, and a growing emphasis on sustainability. Countries such as Germany, France, and the United Kingdom are leading adopters of advanced packaging solutions, including eco-friendly materials and serialization technologies. The European UnionÂ’s focus on reducing plastic waste and promoting circular economy principles is driving the adoption of recyclable and biodegradable packaging materials. The region is projected to grow at a CAGR of 6.1% through 2033, reflecting ongoing investments in innovation and sustainability.

The Asia Pacific region is emerging as the fastest-growing market, with a market size of USD 34.6 billion in 2024 and a projected CAGR of 8.2% through 2033. Rapid urbanization, increasing healthcare expenditures, and the expansion of pharmaceutical manufacturing hubs in countries like China, India, and Japan are driving growth in the region. The rising prevalence of chronic diseases, improving access to healthcare, and government initiatives to promote local pharmaceutical production are further supporting market expansion. Asia Pacific is expected to capture an increasing share of the global pharmaceuticals packaging market over the forecast period, presenting significant opportunities for local and international market participants.

Get Free Sample Report

Competitor Outlook

The pharmaceuticals packaging market is highly competitive, characterized by the presence of global and regional players vying for market share through innovation, quality, and strategic partnerships. The competitive landscape is shaped by continuous investments in research and development, technological advancements, and the adoption of sustainable practices. Leading companies are focusing on expanding their product portfolios, enhancing manufacturing capabilities, and strengthening their presence in high-growth regions. Mergers and acquisitions, collaborations, and joint ventures are common strategies employed by market participants to gain a competitive edge and accelerate growth.

Innovation is a key differentiator in the pharmaceuticals packaging market, with companies investing in smart packaging technologies, advanced materials, and automation to meet evolving industry needs. The integration of digital technologies, such as serialization, track-and-trace, and electronic dose monitoring, is enabling companies to enhance product security, compliance, and patient engagement. Sustainability is also emerging as a critical focus area, with leading players developing eco-friendly packaging solutions and adopting circular economy principles. The ability to offer customized, high-quality, and compliant packaging solutions is essential for success in this dynamic market.

Regional players are leveraging their local expertise and relationships to cater to the specific needs of domestic markets, particularly in emerging economies. These companies are focusing on cost-effective solutions, regulatory compliance, and rapid response to market changes. The increasing trend towards contract packaging and outsourcing is creating opportunities for specialized players to expand their service offerings and capture a larger share of the market. Collaboration between pharmaceutical companies, packaging suppliers, and technology providers is fostering innovation and driving the development of integrated packaging solutions.

Some of the major companies operating in the pharmaceuticals packaging market include Amcor plc, Gerresheimer AG, West Pharmaceutical Services, Inc., Schott AG, Berry Global Inc., AptarGroup, Inc., Becton, Dickinson and Company (BD), WestRock Company, and Catalent, Inc. Amcor plc is a global leader in packaging solutions, known for its focus on innovation, sustainability, and customer-centricity. Gerresheimer AG specializes in glass and plastic packaging for pharmaceuticals and healthcare, with a strong emphasis on quality and regulatory compliance. West Pharmaceutical Services, Inc. is renowned for its expertise in injectable packaging and delivery systems, offering a wide range of products for biologics and specialty drugs.

Schott AG is a leading supplier of glass packaging for pharmaceuticals, with a focus on high-quality vials, ampoules, and syringes. Berry Global Inc. is a major provider of plastic packaging solutions, leveraging advanced manufacturing technologies and sustainability initiatives. AptarGroup, Inc. is known for its innovative dispensing solutions and focus on patient-centric packaging. Becton, Dickinson and Company (BD) is a global leader in medical technology and packaging, offering a comprehensive portfolio of products for drug delivery and administration. WestRock Company specializes in paper-based packaging solutions, supporting the industryÂ’s shift towards sustainability. Catalent, Inc. is a leading provider of contract packaging and manufacturing services, enabling pharmaceutical companies to accelerate product development and commercialization.

These companies are continuously investing in research and development, expanding their manufacturing capabilities, and exploring new markets to strengthen their competitive positions. Strategic partnerships, acquisitions, and collaborations are enabling them to leverage complementary strengths, access new technologies, and enhance their value propositions. The competitive landscape of the pharmaceuticals packaging market is expected to remain dynamic, with ongoing innovation, regulatory changes, and evolving customer needs shaping the future of the industry.

Key Players

• Amcor plc
• WestRock Company
• Gerresheimer AG
• Berry Global Inc.
• Schott AG
• AptarGroup, Inc.
• West Pharmaceutical Services, Inc.
• SGD Pharma
• Becton, Dickinson and Company (BD)
• Owens-Illinois, Inc.
• Sonoco Products Company
• CCL Industries Inc.
• Catalent, Inc.
• International Paper Company
• Nipro Corporation
• Stevanato Group
• Tekni-Plex, Inc.
• Sealed Air Corporation
• Clondalkin Group Holdings B.V.
• Constantia Flexibles Group GmbH

Get Free Sample Report